Atlas Trials

Evergreen Therapeutics, Inc.

6 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Evergreen Therapeutics, Inc.

RecordFirmDate
Efficacy and Safety of a Repurposed Drug Added to the Combination of Len Plus Pem in Advanced Endometrial Cancer (NCT05077215)Evergreen Therapeutics, Inc.2026-12-01
Safety Lead-In Study of a Repurposed Drug Added to the Combination of Len Plus Pem (NCT05106127)Evergreen Therapeutics, Inc.2026-08-01
Study to Evaluate Safety and Efficacy of EG-301 in Patients With Nonfocal Geographic Atrophy Secondary to Dry-AMD (NCT05170048)Evergreen Therapeutics, Inc.2026-06-01
Pharmacokinetic Study to Evaluate Safety and Tolerability of EG-101 in Healthy Female Volunteers as a Safety Lead-In for Dosing in Pregnant Women With Severe Pre-eclampsia (NCT07327255)Evergreen Therapeutics, Inc.2026-06-01
Study to Evaluate the Efficacy and Safety of EG-009A Compared to DEX in Patients With COVID-19 Pneumonia (NCT04561180)Evergreen Therapeutics, Inc.2022-03-04
EG-501 for Cognitive Impairment in Neuropsychiatric SLE (NPSLE): Efficacy and Safety Study (NCT07281105)Evergreen Therapeutics, Inc.2018-08-23

Track Evergreen Therapeutics, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.